LICHENSTEIN, Henri,BEEHARRY, Neil,LANDRETTE, Sean,GAYLE, Sophia,GROTZKE, Jeff,HERNANDEZ, Marylens,YOUNG, Peter R.,ROTHBERG, Jonathan M.
申请号：
AU2018341571
公开号：
AU2018341571A8
申请日:
2018.09.27
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The disclosure provides methods for treating cancer, including but not limited to, hematopoietic and lung cancers, using the HSP90 inhibitor, MPC-0767, as monotherapy and in combination therapy with additional active agents, including but not limited to, inhibitors of Bcl -2, EZH2 inhibitors, Ras/Raf/MEK/ERK pathway inhibitors, checkpoint inhibitors, DNMT inhibitors, ATO and chemotherapeutic agents. The disclosure also provides related compositions and methods of use.
